logo-loader

Proactive news snapshot: Avacta, ValiRx, Minds + Machines Group …

A glance at some of the day's highlights from the Proactive Investors newswire

Newspapers
Your daily round-up from the world of Proactive

Avacta Group PLC (LON:AVCT) has agreed a development partnership and licence agreement with South Korea’s LG Group, to develop Affimer therapeutics in several disease areas.

ValiRx Plc (LON:VAL) has recorded a “statistically significant dose dependant response” for its VAL201 treatment in a Phase I/II clinical trial regarding its effect on prostate cancer.

Minds + Machines Group Limited (LON:MMX), the top-level domain (TLD) registry company, said its initial investment into the .luxe TLD has been recouped within the first four weeks of launch.

Kromek Group PLC (LON:KMK) has been awarded its first contract for biological threat detection from the Defense Advanced Research Projects Agency (DARPA), part of the US Department of Defense.

Orphan drug developer Amryt Pharma PLC (LON:AMYT) is part of a consortium which has been awarded an €8.4mln grant from the Irish government to help develop its AP103 gene therapy platform. The grants, to be received in various instalments over the next three years, will be matched by the consortium, which also includes University College Dublin, Curran Scientific Limited and DEBRA Ireland.

Construction materials group SigmaRoc PLC (LON:ARC) has snapped up concrete blocks and paving stones maker CCP Building Products for £15.21mln. SigmaRoc said CCP is the “right next step” and will be an “excellent addition” which will add value to the business.

Shore Capital has pointed that the first week in December has been “an exciting time construction-wise” for Sirius Minerals PLC (LON:SXX) as it advances the Woodsmith polyhalite mine in Yorkshire, with a number of significant miles achieved.

Silence Therapeutics PLC (LON:SLN) announced on Monday that it has reached a settlement and license agreement with Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) which resolves all patent legal proceedings between the two firms.

The world’s largest producer of insulin is to use e-Therapeutics PLC’s (LON:ETX) Network-Driven Drug Discovery (NDD) platform as it looks to discover new ways of treating type-2 diabetes.

Live Company Group Plc (LON:LVCG) has unveiled a new location for its BRICKLIVE Animal Paradise touring show, Haikou City in China.

There is to be a changing of the guard at IT and communications service provider AdEPT Technology Group PLC (LON:ADT), with long-serving chief executive and founder Ian Fishwick moving into the role of chairman at the beginning of 2019.

Jubilee Metals Group PLC (LON:JLP) is acquiring rights to all the chrome at the PlatCro project in South Africa, where it already controls the platinum group elements. The operation is already in production and is currently processing 75,000 tonnes of ore per month from a resource base of over 1.8mln tonnes.

Metal Tiger PLC (LON:MTR) has intersected wide zones of finely disseminated chalcocite and bornite copper mineralisation from 85 metres to 385 metres downhole a the Tshukudu exploration joint venture in Botswana.

Soil sampling and ground-based magnetic surveys conducted by Kavango Resources PLC (LON:KAV) on its KSZ project in Botswana have confirmed the existence of several potentially mineralised structures.

Kibo Energy PLC (LON:KIBO) announced that its 60%-owned UK subsidiary, MAST Energy Developments Limited has secured an exclusive option for the potential acquisition of three peaking power sites totalling 31.3 megawatts (MW). The multi-asset, energy company said it has paid a nominal fee to undertake due diligence and negotiate the deal.

Range Resources Limited (LON:RRL) (ASX:RRS), the company with oil and gas projects and oilfield service businesses in Trinidad and Indonesia, announced that Yan Liu has tendered his resignation as its chief executive officer and as an executive director to allow him to focus on other business interests, effective immediately. The group said its board will consider a replacement CEO as appropriate, and added that in the interim, Zhiwei (Kerry) Gu will assume the role of executive chairman.

Solo Oil PLC (LON:SOLO) told investors it is looking forward to further updates from Tanzanian partner Aminex plc (LON:AEX) after the Kiliwani North project operator this morning confirmed the successful completion of remedial work for the production well.

Aminex plc (LON:AEX) has confirmed the successful completion of remedial work for the Kiliwani North-1 production well in Tanzania. The company, in a statement, revealed that the work had now addressed the previously reported problem with the well’s sub surface safety valve.

IronRidge Resources LTD (LON:IRR) has commenced a 3,000 metre reverse circulation drilling programme on its Cape Coast lithium portfolio in Ghana. The focus will be on the Abonko target and on the Ewoyaa project northern extension zone, where pegmatite mineralisation remains open.

Europa Metals Ltd (LON:EUZ)(ASX:EUZ) has released results of a scoping study carried out on its Toral lead-zinc-silver project in Spain.

W Resources PLC (LON:WRES) has today announced the mechanical completion of the La Parrilla crusher plant. It paves the way for commissioning of mined ore from the Spanish project during January, the company said in a stock market statement.

Circassia Pharmaceuticals PLC (LON:CIR) has confirmed that it plans to move trading in its shares to AIM and de-list from London Stock Exchange's Main Market. The group said the proposal follows Circassia's commitment to the FCA to seek shareholder approval for admission to AIM if the free float in the company's shares, which excludes shareholdings of more than 5% and those of directors, does not reach the required minimum level of 25%. Conditional on, amongst other things, a resolution being passed at a General Meeting, it is expected that the company's ordinary shares will be admitted to trading on AIM on or around 8am on 4 February 2019.

Alba Mineral Resources PLC (LON:ALBA) confirmed that it will be holding a shareholder update meeting and presentation followed by a Q&A session on 10 December 2018, at 6:30 pm at 1 America Square conference centre, 17 Crosswall Street, London EC3N 2LB.  It said its executive chairman, George Frangeskides will host the meeting along with key members of the executive team.  The group said the presentation will also be available on the company's website after the shareholder meeting.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ValiRx PLC named herein, including the promotion by the Company of ValiRx PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: BB Healthcare steadfast after rollercoaster 2019 for...

Should global politics and trade wars affect healthcare investments? Probably not - but they do, according to Investment Advisor and keen current affairs watcher at BB Healthcare Trust (LON:BBH) Paul Major. Major usefully highlights for Proactive London the folly of watching politics too...

35 minutes ago

6 min read